| 2024-06-12 |
HLCUGOAODAUHF9AA |
XELLIA PHARMACEUTICALS APS |
13518.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600229 |
| 2024-05-02 |
HLCUGOAOD36330AA |
XELLIA PHARMACEUTICALS APS |
4707.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600167 |
| 2024-04-27 |
HLCUGOAOC71494AA |
XELLIA PHARMACEUTICALS APS |
27192.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600168 VANCOMYCIN HS CODE 3004.2000 NDA NR 600169 |
| 2024-04-11 |
HLCUGOAOB87835AA |
XELLIA PHARMACEUTICALS APS |
54092.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600131+600132 VANCOMYCIN HS CODE 3004.2000 NDA NR 600135 VANCOMYCIN HS CODE 3004.2000 NDA NR 600129+600130 VANCOMYCIN HS CODE 3004.2000 NDA NR 600133+600134 |
| 2024-04-09 |
HLCUGOAOB87920AA |
XELLIA PHARMACEUTICALS APS |
51190.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600112+600113 VANCOMYCIN HS CODE 3004.2000 NDA NR 600111 VANCOMYCIN HS CODE 3004.2000 NDA NR 600114+600115 VANCOMYCIN HS CODE 3004.2000 NDA NR 600116+600117 |
| 2024-03-20 |
HLCUGOAOB94241AA |
XELLIA PHARMACEUTICALS APS |
56473.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600084-600085-600086 VANCOMYCIN HS CODE 3004.2000 NDA NR 600087 VANCOMYCIN HS CODE 3004.2000 NDA NR 600088 VANCOMYCIN HS CODE 3004.2000 NDA NR 600079 VANCOMYCIN HS CODE 3004.2000 NDA NR 600080+600081 |
| 2024-01-02 |
HLCUGOANK69717AA |
XELLIA PHARMACEUTICALS APS |
40742.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13190 VANCOMYCIN HS CODE 3004.2000 NDA NR 13188 VANCOMYCIN HS CODE 3004.2000 NDA NR 13189 VANCOMYCIN HS CODE 3004.2000 NDA NR 13191+13192+13193 |
| 2023-12-29 |
HLCUGOANK69622AA |
XELLIA PHARMACEUTICALS APS |
31676.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13175 VANCOMYCIN HS CODE 3004.2000 NDA NR 13173+13174 VANCOMYCIN HS CODE 3004.2000 NDA NR 13171+13172 |
| 2023-12-14 |
HLCUGOANK11735AA |
XELLIA PHARMACEUTICALS APS |
24378.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13150+12301 VANCOMYCIN HS CODE 3004.2000 NDA NR 131512+12303 |
| 2023-12-08 |
HLCUGOANJAWRR0AA |
XELLIA PHARMACEUTICALS APS |
39809.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13129 VANCOMYCIN HS CODE 3004.2000 NDA NR 13130 VANCOMYCIN HS CODE 3004.2000 NDA NR 13131 |
| 2023-11-27 |
HLCUGOANJATAS7AA |
XELLIA PHARMACEUTICALS APS |
30453.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13119 VANCOMYCIN HS CODE 3004.2000 NDA NR 13117+13118 VANCOMYCIN HS CODE 3004.2000 NDA NR 13115+13116 |
| 2023-11-10 |
HLCUGOANJ50930AA |
XELLIA PHARMACEUTICALS APS |
37890.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13093 VANCOMYCIN HS CODE 3004.2000 NDA NR 13096+13097 VANCOMYCIN HS CODE 3004.2000 NDA NR 13094+13095 |
| 2023-11-01 |
HLCUGOANJ08181AA |
XELLIA PHARMACEUTICALS APS |
39947.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13076+13077 VANCOMYCIN HS CODE 3004.2000 NDA NR 13079 VANCOMYCIN HS CODE 3004.2000 NDA NR 13078 |
| 2023-10-25 |
HLCUGOANIASBN5AA |
XELLIA PHARMACEUTICALS APS |
12653.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 0013057 |
| 2023-10-22 |
HLCUGOANI82538AA |
XELLIA PHARMACEUTICALS APS |
59527.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 0013036+0013037 VANCOMYCIN HS CODE 3004.2000 NDA NR 0013034+0013035 VANCOMYCIN HS CODE 3004.2000 NDA NR 0013045 VANCOMYCIN HS CODE 3004.2000 NDA NR 0013043+0013044 VANCOMYCIN HS CODE 3004.2000 NDA NR 0013033 |
| 2023-10-11 |
HLCUGOANI38309AA |
XELLIA PHARMACEUTICALS APS |
22210.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13023 VANCOMYCIN HS CODE 3004.2000 NDA NR 13024+13025 |
| 2023-10-05 |
HLCUGOANI07351AA |
XELLIA PHARMACEUTICALS APS |
39055.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 0012997 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012996 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012995 |
| 2023-09-28 |
HLCUGOANH99430AA |
XELLIA PHARMACEUTICALS APS |
38657.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 0012982 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012980 + 0012981 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012983 |
| 2023-09-21 |
HLCUGOANH71183AA |
XELLIA PHARMACEUTICALS APS |
39286.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 0012962 + 0012963 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012960 + 0012961 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012958 + 0012959 |
| 2023-09-14 |
HLCUGOANGAVLA6AA |
XELLIA PHARMACEUTICALS APS |
26197.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12942 VANCOMYCIN HS CODE 3004.2000 NDA NR 12928+12931 |
| 2023-08-28 |
HLCUGOANG76006AA |
XELLIA PHARMACEUTICALS APS |
26758.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 0012924 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012925/0012932 |
| 2023-08-21 |
HLCUGOANG75471AA |
XELLIA PHARMACEUTICALS APS |
23737.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 0012909+0012910 VANCOMYCIN HS CODE 3004.2000 NDA NR 0012911 |
| 2023-07-28 |
HLCUGOANFASHX3AA |
XELLIA PHARMACEUTICALS APS |
54759.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12855+12856 VANCOMYCIN HS CODE 3004.2000 NDA NR 12857+12858 VANCOMYCIN HS CODE 3004.2000 NDA NR 12853 VANCOMYCIN HS CODE 3004.2000 NDA NR 12854 |
| 2023-07-19 |
HLCUGOANF92796AA |
XELLIA PHARMACEUTICALS APS |
37563.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12834+12835 VANCOMYCIN HS CODE 3004.2000 NDA NR 12836+12837 VANCOMYCIN HS CODE 3004.2000 NDA NR 12832+12833 |
| 2023-07-13 |
HLCUGOANF59438AA |
XELLIA PHARMACEUTICALS APS |
37775.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12815+12816 VANCOMYCIN HS CODE 3004.2000 NDA NR 12813+12814 VANCOMYCIN HS CODE 3004.2000 NDA NR 12812 |
| 2023-07-08 |
HLCUGOANF42622AA |
XELLIA PHARMACEUTICALS APS |
13573.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12795+12796 |
| 2023-06-19 |
HLCUGOANEAQQS9AA |
XELLIA PHARMACEUTICALS APS |
24381.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12743 VANCOMYCIN HS CODE 3004.2000 NDA NR 12742 |
| 2023-06-12 |
HLCUGOANEAQSD5AA |
XELLIA PHARMACEUTICALS APS |
26414.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12731 VANCOMYCIN HS CODE 3004.2000 NDA NR 12732 |
| 2023-04-27 |
HLCUGOANC72364AA |
XELLIA PHARMACEUTICALS APS |
35925.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12595 VANCOMYCIN HS CODE 3004.2000 NDA NR 12594 VANCOMYCIN HS CODE 3004.2000 NDA NR 12596+12597 |
| 2023-03-31 |
HLCUGOANC09314AA |
XELLIA PHARMACEUTICALS APS |
25356.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12531-12532 VANCOMYCIN HS CODE 3004.2000 NDA NR 12530 |
| 2023-02-18 |
HLCUGOANA30451AA |
XELLIA PHARMACEUTICALS APS |
53853.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12412+12413 VANCOMYCIN HS CODE 3004.2000 NDA NR 12425 VANCOMYCIN HS CODE 3004.2000 NDA NR 12411 VANCOMYCIN HS CODE 3004.2000 NDA NR 12409 |
| 2023-01-12 |
HLCUGOAMKAZYE3AA |
XELLIA PHARMACEUTICALS APS |
38063.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12329+12330 VANCOMYCIN HS CODE 3004.2000 NDA NR 12328 VANCOMYCIN HS CODE 3004.2000 NDA NR 12331+12332 |
| 2022-12-31 |
HLCUGOAMK47356AA |
XELLIA PHARMACEUTICALS APS |
23293.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 12286+12301 VANCOMYCIN HS CODE 3004.2000 NDA NR 12302+12303 |